Form 4: Biogen Director Stephen Sherwin Sells 8,760 Shares of Common Stock

Director Stephen Sherwin sold 8,760 shares of Biogen (BIIB) common stock at a price of $150.0162 on March 7, 2025.

Summary

• On March 7, 2025, Stephen Sherwin, a director at Biogen Inc. (BIIB), sold 8,760 shares of the company's common stock.
• The sale price was $150.0162 per share.
• Following the transaction, Sherwin directly owns 11,318 shares of Biogen common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing a stock sale by a company director. It doesn't inherently convey positive or negative sentiment, but the sale itself could be interpreted in various ways by the market.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders, like directors and officers, trade their company's stock. These filings provide transparency into insider transactions, allowing investors to see if those with inside knowledge of the company are buying or selling shares.

Stakeholder Impact

• The sale of shares by a director could potentially influence investor sentiment, although the impact is likely to be minimal given the size of the transaction relative to the company's overall market capitalization.

Key Dates